Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARA-002 in Macrocystic and Mixed Cystic Lymphatic Malformations
NCT05871970Phase 2Recruiting
- Sponsor
- Protara Therapeutics
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of TARA-002 in Lymphatic Malformation (LM), sponsored by Protara Therapeutics. Started Oct 2023; status: recruiting.
02
Drugs
TARA-002
03
Conditions
Lymphatic Malformation (LM)
Beyond the preview
Go deeper on NCT05871970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05871970.